Copyright
©The Author(s) 2021.
World J Diabetes. Jul 15, 2021; 12(7): 975-996
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.975
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.975
Figure 1 Non-invasive assessment of cardiovascular risk in patients with diabetes mellitus and chronic kidney disease.
GFR: Glomerular filtration rate; CKD-MBD: Chronic kidney disease mineral bone disorder; hsCRP: High sensitivity C-reactive protein; sVCAM-1: Soluble vascular cell adhesion molecule-1; sICAM-1: Soluble intercellular adhesion molecule-1; IL-1:Interleukin-1; IL-6: Interleukin-6; IL-18: Interleukin-18; TNF-α: Tumor necrosis factor-α; ABPM: Ambulatory blood pressure measurements; BP: Blood pressure; ABI: Ankle-brachial index; cfPWV: Carotid-femoral pulse wave velocity; SEVR: Subendocardial viability ratio; AIx: Augmentation index; AIx@75: AIx adjusted for heart rate 75/min; ED: Ejection duration; AP: Augmentation pressure; PP: Pulse pressure; CTA: Computed tomography angiography; MRI: Magnetic resonance imaging; lncRNAs: Long non-coding ribonucleic acids; miRNAs: Micro-ribonucleic acids.
- Citation: Piko N, Bevc S, Ekart R, Petreski T, Vodošek Hojs N, Hojs R. Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk. World J Diabetes 2021; 12(7): 975-996
- URL: https://www.wjgnet.com/1948-9358/full/v12/i7/975.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i7.975